A better option for stroke prevention?
A class of drugs called direct oral anticoagulant may be a safer choice for people with atrial fibrillation.
Image: © ttsz /Thinkstock
For more than 60 years, people at high risk for stroke from atrial fibrillation (afib) — an irregular heartbeat that can lead to blood clots — had one choice of drug treatment: warfarin.
But new research has helped raise the profile of another type of medication called direct oral anticoagulant (DOACs), which appear to be just as effective as warfarin, but without many of warfarin's side effects.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
